EZH2 and breast carcinoma: Cho et al. demonstrated that RES downregulated amphiregulin expression caused by LPA as well as blocked the Y-box binding protein-1 (YB-1)/enhancer of zeste homolog 2 (EZH2) signaling pathway to inhibit the invasion of breast cancer cell.